Medication use patterns after gastric bypass surgery for weight management

Annals of Pharmacotherapy

Volumn 39, Issue 4, 2005, Pages 637-642

  Malone, Margaret ^a   Alger Mayer, Sharon A ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Gastric bypass; Medication use; Obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMFEBUTAMONE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT HUMAN INSULIN; SEROTONIN UPTAKE INHIBITOR; SULFONYLUREA; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE DISTRIBUTION; ANXIETY DISORDER; BARIATRIC SURGERY; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DRUG USE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOARTHRITIS; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STOMACH BYPASS; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

ADULT; DIETARY SUPPLEMENTS; FEMALE; GASTRIC BYPASS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; SELF ADMINISTRATION; WEIGHT LOSS;

EID: 15444366424     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E393     Document Type: Review

References (22)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-7.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
3. American Gastroenterological Association Clinical Practice Committee. AGA technical review on obesity. Gastroenterology 2002;123:882-932.
4. Kushner R. Managing the obese patient after bariatric surgery: a case report of severe malnutrition and review of the literature. JPEN J Parenter Enteral Nutr 2000;24:126-32.
5. Steinbrook R. Surgery for severe obesity. N Engl J Med 2004;350:1075-9.
6. Malone M. Altered drug disposition in obesity and after bariatric surgery. Nutr Clin Pract 2003;18:131-5.
7. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery. JAMA 2004;292:1724-37.
8. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995; 222:339-50.
9. Mason EE, Renquist KE. Gallbladder management in obesity surgery. Obes Surg 2002;12:222-9.
10. Malone M, Alger SA. Binge status and quality of life after gastric bypass surgery: a one year study. Obes Res 2004;12:473-81.
11. Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci 1994;39:315-20.
12. 12 deficiency anemia: oral versus parenteral therapy. Ann Pharmacother 2002;36:1268-72. DOI 10.1345/aph.1A122
13. Mallory GN, Macgregor AMC. Folate status following gastric bypass surgery. Obes Surg 1991;1:69-72.
14. Burge JC, Schaumburg JZ, Choban PS, DiSilvestro RA, Flancbaum L. Changes in patients' taste acuity after Roux-en-Y gastric bypass for clinically severe obesity. J Am Diet Assoc 1995;95:666-70.
15. Neve HJ, Bhatti WA, Soulsby C, Kincey J, Taylor TV. Reversal of hair loss following vertical gastroplasty when treated with zinc sulphate. Obes Surg 1996;6:63-5.
16. Rhode BM, Shustik C, Christou NV, MacLean D. Iron absorption and therapy after gastric bypass. Obes Surg 1999;9:17-21.
17. Bano G, Rodin DA, Pazianas M, Nussey SS. Reduced bone mineral density after surgical treatment for obesity. Int J Obes Relat Metab Disord 1999;23:361-5.
18. Sjostrom CD, Peltonen M, Wedel J, Sjostrom L. Differentiated long term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000;36:20-5.
19. Agren G, Narbro K, Naslund I, Sjostrom L, Peltonen M. Long term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention study. Int J Obes 2002;26:184-92.
20. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals. Arch Intern Med 2002;162:2061-9.
21. Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med 1994;154:193-200.
22. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004;89:2608-15.